▶ 調査レポート

筋骨格系生体材料の世界市場(~2026年)

• 英文タイトル:Global Biomaterials for Musculoskeletal Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。筋骨格系生体材料の世界市場(~2026年) / Global Biomaterials for Musculoskeletal Market Insights and Forecast to 2026 / MRC2-11QY03248資料のイメージです。• レポートコード:MRC2-11QY03248
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、152ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は筋骨格系生体材料のグローバル市場について調査・分析したレポートです。種類別(金属生体材料、高分子生体材料、無機非金属生体材料)市場規模、用途別(オステオパシー治療、研究)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別筋骨格系生体材料の競争状況、市場シェア
・世界の筋骨格系生体材料市場:種類別市場規模 2015年-2020年(金属生体材料、高分子生体材料、無機非金属生体材料)
・世界の筋骨格系生体材料市場:種類別市場規模予測 2021年-2026年(金属生体材料、高分子生体材料、無機非金属生体材料)
・世界の筋骨格系生体材料市場:用途別市場規模 2015年-2020年(オステオパシー治療、研究)
・世界の筋骨格系生体材料市場:用途別市場規模予測 2021年-2026年(オステオパシー治療、研究)
・北米の筋骨格系生体材料市場分析:米国、カナダ
・ヨーロッパの筋骨格系生体材料市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの筋骨格系生体材料市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の筋骨格系生体材料市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの筋骨格系生体材料市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Pfizer、Abbott、Johnson & Johnson、Merck、Amgen、Roche、BMS、Medtronic、AB Science、Zimmer Biomet、Arthrex、Stryker、Smith & Nephew、Baxter、Orthofix、RTI Biologics
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Biomaterials for Musculoskeletal Market
The global Biomaterials for Musculoskeletal market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Biomaterials for Musculoskeletal Scope and Market Size
Biomaterials for Musculoskeletal market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biomaterials for Musculoskeletal market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Biomaterials for Musculoskeletal market is segmented into
Metallic Biomaterials
Polymeric Biomaterials
Inorganic Non-Metallic Biomaterials

Segment by Application, the Biomaterials for Musculoskeletal market is segmented into
Osteopathic Treatment
Research

Regional and Country-level Analysis
The Biomaterials for Musculoskeletal market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biomaterials for Musculoskeletal market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biomaterials for Musculoskeletal Market Share Analysis
Biomaterials for Musculoskeletal market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biomaterials for Musculoskeletal business, the date to enter into the Biomaterials for Musculoskeletal market, Biomaterials for Musculoskeletal product introduction, recent developments, etc.

The major vendors covered:
Pfizer
Abbott
Johnson & Johnson
Merck
Amgen
Roche
BMS
Medtronic
AB Science
Zimmer Biomet
Arthrex
Stryker
Smith & Nephew
Baxter
Orthofix
RTI Biologics

レポート目次

1 Study Coverage
1.1 Biomaterials for Musculoskeletal Product Introduction
1.2 Market Segments
1.3 Key Biomaterials for Musculoskeletal Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biomaterials for Musculoskeletal Market Size Growth Rate by Type
1.4.2 Metallic Biomaterials
1.4.3 Polymeric Biomaterials
1.4.4 Inorganic Non-Metallic Biomaterials
1.5 Market by Application
1.5.1 Global Biomaterials for Musculoskeletal Market Size Growth Rate by Application
1.5.2 Osteopathic Treatment
1.5.3 Research
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Biomaterials for Musculoskeletal Market Size, Estimates and Forecasts
2.1.1 Global Biomaterials for Musculoskeletal Revenue 2015-2026
2.1.2 Global Biomaterials for Musculoskeletal Sales 2015-2026
2.2 Global Biomaterials for Musculoskeletal, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Biomaterials for Musculoskeletal Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biomaterials for Musculoskeletal Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Biomaterials for Musculoskeletal Competitor Landscape by Players
3.1 Biomaterials for Musculoskeletal Sales by Manufacturers
3.1.1 Biomaterials for Musculoskeletal Sales by Manufacturers (2015-2020)
3.1.2 Biomaterials for Musculoskeletal Sales Market Share by Manufacturers (2015-2020)
3.2 Biomaterials for Musculoskeletal Revenue by Manufacturers
3.2.1 Biomaterials for Musculoskeletal Revenue by Manufacturers (2015-2020)
3.2.2 Biomaterials for Musculoskeletal Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biomaterials for Musculoskeletal Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biomaterials for Musculoskeletal Revenue in 2019
3.2.5 Global Biomaterials for Musculoskeletal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biomaterials for Musculoskeletal Price by Manufacturers
3.4 Biomaterials for Musculoskeletal Manufacturing Base Distribution, Product Types
3.4.1 Biomaterials for Musculoskeletal Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biomaterials for Musculoskeletal Product Type
3.4.3 Date of International Manufacturers Enter into Biomaterials for Musculoskeletal Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Biomaterials for Musculoskeletal Market Size by Type (2015-2020)
4.1.1 Global Biomaterials for Musculoskeletal Sales by Type (2015-2020)
4.1.2 Global Biomaterials for Musculoskeletal Revenue by Type (2015-2020)
4.1.3 Biomaterials for Musculoskeletal Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biomaterials for Musculoskeletal Market Size Forecast by Type (2021-2026)
4.2.1 Global Biomaterials for Musculoskeletal Sales Forecast by Type (2021-2026)
4.2.2 Global Biomaterials for Musculoskeletal Revenue Forecast by Type (2021-2026)
4.2.3 Biomaterials for Musculoskeletal Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biomaterials for Musculoskeletal Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Biomaterials for Musculoskeletal Market Size by Application (2015-2020)
5.1.1 Global Biomaterials for Musculoskeletal Sales by Application (2015-2020)
5.1.2 Global Biomaterials for Musculoskeletal Revenue by Application (2015-2020)
5.1.3 Biomaterials for Musculoskeletal Price by Application (2015-2020)
5.2 Biomaterials for Musculoskeletal Market Size Forecast by Application (2021-2026)
5.2.1 Global Biomaterials for Musculoskeletal Sales Forecast by Application (2021-2026)
5.2.2 Global Biomaterials for Musculoskeletal Revenue Forecast by Application (2021-2026)
5.2.3 Global Biomaterials for Musculoskeletal Price Forecast by Application (2021-2026)

6 North America
6.1 North America Biomaterials for Musculoskeletal by Country
6.1.1 North America Biomaterials for Musculoskeletal Sales by Country
6.1.2 North America Biomaterials for Musculoskeletal Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biomaterials for Musculoskeletal Market Facts & Figures by Type
6.3 North America Biomaterials for Musculoskeletal Market Facts & Figures by Application

7 Europe
7.1 Europe Biomaterials for Musculoskeletal by Country
7.1.1 Europe Biomaterials for Musculoskeletal Sales by Country
7.1.2 Europe Biomaterials for Musculoskeletal Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biomaterials for Musculoskeletal Market Facts & Figures by Type
7.3 Europe Biomaterials for Musculoskeletal Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Biomaterials for Musculoskeletal by Region
8.1.1 Asia Pacific Biomaterials for Musculoskeletal Sales by Region
8.1.2 Asia Pacific Biomaterials for Musculoskeletal Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biomaterials for Musculoskeletal Market Facts & Figures by Type
8.3 Asia Pacific Biomaterials for Musculoskeletal Market Facts & Figures by Application

9 Latin America
9.1 Latin America Biomaterials for Musculoskeletal by Country
9.1.1 Latin America Biomaterials for Musculoskeletal Sales by Country
9.1.2 Latin America Biomaterials for Musculoskeletal Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biomaterials for Musculoskeletal Market Facts & Figures by Type
9.3 Central & South America Biomaterials for Musculoskeletal Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Biomaterials for Musculoskeletal by Country
10.1.1 Middle East and Africa Biomaterials for Musculoskeletal Sales by Country
10.1.2 Middle East and Africa Biomaterials for Musculoskeletal Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Biomaterials for Musculoskeletal Market Facts & Figures by Type
10.3 Middle East and Africa Biomaterials for Musculoskeletal Market Facts & Figures by Application

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Biomaterials for Musculoskeletal Products Offered
11.1.5 Pfizer Related Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Description and Business Overview
11.2.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Abbott Biomaterials for Musculoskeletal Products Offered
11.2.5 Abbott Related Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Description and Business Overview
11.3.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Johnson & Johnson Biomaterials for Musculoskeletal Products Offered
11.3.5 Johnson & Johnson Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Biomaterials for Musculoskeletal Products Offered
11.4.5 Merck Related Developments
11.5 Amgen
11.5.1 Amgen Corporation Information
11.5.2 Amgen Description and Business Overview
11.5.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Amgen Biomaterials for Musculoskeletal Products Offered
11.5.5 Amgen Related Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Description and Business Overview
11.6.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Roche Biomaterials for Musculoskeletal Products Offered
11.6.5 Roche Related Developments
11.7 BMS
11.7.1 BMS Corporation Information
11.7.2 BMS Description and Business Overview
11.7.3 BMS Sales, Revenue and Gross Margin (2015-2020)
11.7.4 BMS Biomaterials for Musculoskeletal Products Offered
11.7.5 BMS Related Developments
11.8 Medtronic
11.8.1 Medtronic Corporation Information
11.8.2 Medtronic Description and Business Overview
11.8.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Medtronic Biomaterials for Musculoskeletal Products Offered
11.8.5 Medtronic Related Developments
11.9 AB Science
11.9.1 AB Science Corporation Information
11.9.2 AB Science Description and Business Overview
11.9.3 AB Science Sales, Revenue and Gross Margin (2015-2020)
11.9.4 AB Science Biomaterials for Musculoskeletal Products Offered
11.9.5 AB Science Related Developments
11.10 Zimmer Biomet
11.10.1 Zimmer Biomet Corporation Information
11.10.2 Zimmer Biomet Description and Business Overview
11.10.3 Zimmer Biomet Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Zimmer Biomet Biomaterials for Musculoskeletal Products Offered
11.10.5 Zimmer Biomet Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Biomaterials for Musculoskeletal Products Offered
11.1.5 Pfizer Related Developments
11.12 Stryker
11.12.1 Stryker Corporation Information
11.12.2 Stryker Description and Business Overview
11.12.3 Stryker Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Stryker Products Offered
11.12.5 Stryker Related Developments
11.13 Smith & Nephew
11.13.1 Smith & Nephew Corporation Information
11.13.2 Smith & Nephew Description and Business Overview
11.13.3 Smith & Nephew Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Smith & Nephew Products Offered
11.13.5 Smith & Nephew Related Developments
11.14 Baxter
11.14.1 Baxter Corporation Information
11.14.2 Baxter Description and Business Overview
11.14.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Baxter Products Offered
11.14.5 Baxter Related Developments
11.15 Orthofix
11.15.1 Orthofix Corporation Information
11.15.2 Orthofix Description and Business Overview
11.15.3 Orthofix Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Orthofix Products Offered
11.15.5 Orthofix Related Developments
11.16 RTI Biologics
11.16.1 RTI Biologics Corporation Information
11.16.2 RTI Biologics Description and Business Overview
11.16.3 RTI Biologics Sales, Revenue and Gross Margin (2015-2020)
11.16.4 RTI Biologics Products Offered
11.16.5 RTI Biologics Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biomaterials for Musculoskeletal Market Estimates and Projections by Region
12.1.1 Global Biomaterials for Musculoskeletal Sales Forecast by Regions 2021-2026
12.1.2 Global Biomaterials for Musculoskeletal Revenue Forecast by Regions 2021-2026
12.2 North America Biomaterials for Musculoskeletal Market Size Forecast (2021-2026)
12.2.1 North America: Biomaterials for Musculoskeletal Sales Forecast (2021-2026)
12.2.2 North America: Biomaterials for Musculoskeletal Revenue Forecast (2021-2026)
12.2.3 North America: Biomaterials for Musculoskeletal Market Size Forecast by Country (2021-2026)
12.3 Europe Biomaterials for Musculoskeletal Market Size Forecast (2021-2026)
12.3.1 Europe: Biomaterials for Musculoskeletal Sales Forecast (2021-2026)
12.3.2 Europe: Biomaterials for Musculoskeletal Revenue Forecast (2021-2026)
12.3.3 Europe: Biomaterials for Musculoskeletal Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biomaterials for Musculoskeletal Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biomaterials for Musculoskeletal Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biomaterials for Musculoskeletal Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biomaterials for Musculoskeletal Market Size Forecast by Region (2021-2026)
12.5 Latin America Biomaterials for Musculoskeletal Market Size Forecast (2021-2026)
12.5.1 Latin America: Biomaterials for Musculoskeletal Sales Forecast (2021-2026)
12.5.2 Latin America: Biomaterials for Musculoskeletal Revenue Forecast (2021-2026)
12.5.3 Latin America: Biomaterials for Musculoskeletal Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biomaterials for Musculoskeletal Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biomaterials for Musculoskeletal Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biomaterials for Musculoskeletal Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biomaterials for Musculoskeletal Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Biomaterials for Musculoskeletal Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biomaterials for Musculoskeletal Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Biomaterials for Musculoskeletal Market Segments
Table 2. Ranking of Global Top Biomaterials for Musculoskeletal Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biomaterials for Musculoskeletal Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Metallic Biomaterials
Table 5. Major Manufacturers of Polymeric Biomaterials
Table 6. Major Manufacturers of Inorganic Non-Metallic Biomaterials
Table 7. Global Biomaterials for Musculoskeletal Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Biomaterials for Musculoskeletal Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Biomaterials for Musculoskeletal Sales by Regions 2015-2020 (K MT)
Table 10. Global Biomaterials for Musculoskeletal Sales Market Share by Regions (2015-2020)
Table 11. Global Biomaterials for Musculoskeletal Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Biomaterials for Musculoskeletal Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Biomaterials for Musculoskeletal Sales Share by Manufacturers (2015-2020)
Table 14. Global Biomaterials for Musculoskeletal Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Biomaterials for Musculoskeletal by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biomaterials for Musculoskeletal as of 2019)
Table 16. Biomaterials for Musculoskeletal Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Biomaterials for Musculoskeletal Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Biomaterials for Musculoskeletal Price (2015-2020) (USD/MT)
Table 19. Biomaterials for Musculoskeletal Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Biomaterials for Musculoskeletal Product Type
Table 21. Date of International Manufacturers Enter into Biomaterials for Musculoskeletal Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Biomaterials for Musculoskeletal Sales by Type (2015-2020) (K MT)
Table 24. Global Biomaterials for Musculoskeletal Sales Share by Type (2015-2020)
Table 25. Global Biomaterials for Musculoskeletal Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Biomaterials for Musculoskeletal Revenue Share by Type (2015-2020)
Table 27. Biomaterials for Musculoskeletal Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Biomaterials for Musculoskeletal Sales by Application (2015-2020) (K MT)
Table 29. Global Biomaterials for Musculoskeletal Sales Share by Application (2015-2020)
Table 30. North America Biomaterials for Musculoskeletal Sales by Country (2015-2020) (K MT)
Table 31. North America Biomaterials for Musculoskeletal Sales Market Share by Country (2015-2020)
Table 32. North America Biomaterials for Musculoskeletal Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Biomaterials for Musculoskeletal Revenue Market Share by Country (2015-2020)
Table 34. North America Biomaterials for Musculoskeletal Sales by Type (2015-2020) (K MT)
Table 35. North America Biomaterials for Musculoskeletal Sales Market Share by Type (2015-2020)
Table 36. North America Biomaterials for Musculoskeletal Sales by Application (2015-2020) (K MT)
Table 37. North America Biomaterials for Musculoskeletal Sales Market Share by Application (2015-2020)
Table 38. Europe Biomaterials for Musculoskeletal Sales by Country (2015-2020) (K MT)
Table 39. Europe Biomaterials for Musculoskeletal Sales Market Share by Country (2015-2020)
Table 40. Europe Biomaterials for Musculoskeletal Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Biomaterials for Musculoskeletal Revenue Market Share by Country (2015-2020)
Table 42. Europe Biomaterials for Musculoskeletal Sales by Type (2015-2020) (K MT)
Table 43. Europe Biomaterials for Musculoskeletal Sales Market Share by Type (2015-2020)
Table 44. Europe Biomaterials for Musculoskeletal Sales by Application (2015-2020) (K MT)
Table 45. Europe Biomaterials for Musculoskeletal Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Biomaterials for Musculoskeletal Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Biomaterials for Musculoskeletal Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Biomaterials for Musculoskeletal Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Biomaterials for Musculoskeletal Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Biomaterials for Musculoskeletal Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Biomaterials for Musculoskeletal Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Biomaterials for Musculoskeletal Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Biomaterials for Musculoskeletal Sales Market Share by Application (2015-2020)
Table 54. Latin America Biomaterials for Musculoskeletal Sales by Country (2015-2020) (K MT)
Table 55. Latin America Biomaterials for Musculoskeletal Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Biomaterials for Musculoskeletal Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Biomaterials for Musculoskeletal Revenue Market Share by Country (2015-2020)
Table 58. Latin America Biomaterials for Musculoskeletal Sales by Type (2015-2020) (K MT)
Table 59. Latin America Biomaterials for Musculoskeletal Sales Market Share by Type (2015-2020)
Table 60. Latin America Biomaterials for Musculoskeletal Sales by Application (2015-2020) (K MT)
Table 61. Latin America Biomaterials for Musculoskeletal Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Biomaterials for Musculoskeletal Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Biomaterials for Musculoskeletal Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Biomaterials for Musculoskeletal Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Biomaterials for Musculoskeletal Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Biomaterials for Musculoskeletal Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Biomaterials for Musculoskeletal Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Biomaterials for Musculoskeletal Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Biomaterials for Musculoskeletal Sales Market Share by Application (2015-2020)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Major Businesses
Table 72. Pfizer Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Pfizer Product
Table 74. Pfizer Recent Development
Table 75. Abbott Corporation Information
Table 76. Abbott Description and Major Businesses
Table 77. Abbott Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Abbott Product
Table 79. Abbott Recent Development
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Major Businesses
Table 82. Johnson & Johnson Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Major Businesses
Table 87. Merck Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Merck Product
Table 89. Merck Recent Development
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Major Businesses
Table 92. Amgen Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Amgen Product
Table 94. Amgen Recent Development
Table 95. Roche Corporation Information
Table 96. Roche Description and Major Businesses
Table 97. Roche Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Roche Product
Table 99. Roche Recent Development
Table 100. BMS Corporation Information
Table 101. BMS Description and Major Businesses
Table 102. BMS Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. BMS Product
Table 104. BMS Recent Development
Table 105. Medtronic Corporation Information
Table 106. Medtronic Description and Major Businesses
Table 107. Medtronic Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Medtronic Product
Table 109. Medtronic Recent Development
Table 110. AB Science Corporation Information
Table 111. AB Science Description and Major Businesses
Table 112. AB Science Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. AB Science Product
Table 114. AB Science Recent Development
Table 115. Zimmer Biomet Corporation Information
Table 116. Zimmer Biomet Description and Major Businesses
Table 117. Zimmer Biomet Biomaterials for Musculoskeletal Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Zimmer Biomet Product
Table 119. Zimmer Biomet Recent Development
Table 120. Arthrex Corporation Information
Table 121. Arthrex Description and Major Businesses
Table 122. Arthrex Biomaterials for Musculoskeletal Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Arthrex Product
Table 124. Arthrex Recent Development
Table 125. Stryker Corporation Information
Table 126. Stryker Description and Major Businesses
Table 127. Stryker Biomaterials for Musculoskeletal Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Stryker Product
Table 129. Stryker Recent Development
Table 130. Smith & Nephew Corporation Information
Table 131. Smith & Nephew Description and Major Businesses
Table 132. Smith & Nephew Biomaterials for Musculoskeletal Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Smith & Nephew Product
Table 134. Smith & Nephew Recent Development
Table 135. Baxter Corporation Information
Table 136. Baxter Description and Major Businesses
Table 137. Baxter Biomaterials for Musculoskeletal Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Baxter Product
Table 139. Baxter Recent Development
Table 140. Orthofix Corporation Information
Table 141. Orthofix Description and Major Businesses
Table 142. Orthofix Biomaterials for Musculoskeletal Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Orthofix Product
Table 144. Orthofix Recent Development
Table 145. RTI Biologics Corporation Information
Table 146. RTI Biologics Description and Major Businesses
Table 147. RTI Biologics Biomaterials for Musculoskeletal Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. RTI Biologics Product
Table 149. RTI Biologics Recent Development
Table 150. Global Biomaterials for Musculoskeletal Sales Forecast by Regions (2021-2026) (K MT)
Table 151. Global Biomaterials for Musculoskeletal Sales Market Share Forecast by Regions (2021-2026)
Table 152. Global Biomaterials for Musculoskeletal Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 153. Global Biomaterials for Musculoskeletal Revenue Market Share Forecast by Regions (2021-2026)
Table 154. North America: Biomaterials for Musculoskeletal Sales Forecast by Country (2021-2026) (K MT)
Table 155. North America: Biomaterials for Musculoskeletal Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Europe: Biomaterials for Musculoskeletal Sales Forecast by Country (2021-2026) (K MT)
Table 157. Europe: Biomaterials for Musculoskeletal Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Asia Pacific: Biomaterials for Musculoskeletal Sales Forecast by Region (2021-2026) (K MT)
Table 159. Asia Pacific: Biomaterials for Musculoskeletal Revenue Forecast by Region (2021-2026) (US$ Million)
Table 160. Latin America: Biomaterials for Musculoskeletal Sales Forecast by Country (2021-2026) (K MT)
Table 161. Latin America: Biomaterials for Musculoskeletal Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Middle East and Africa: Biomaterials for Musculoskeletal Sales Forecast by Country (2021-2026) (K MT)
Table 163. Middle East and Africa: Biomaterials for Musculoskeletal Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 165. Key Challenges
Table 166. Market Risks
Table 167. Main Points Interviewed from Key Biomaterials for Musculoskeletal Players
Table 168. Biomaterials for Musculoskeletal Customers List
Table 169. Biomaterials for Musculoskeletal Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Biomaterials for Musculoskeletal Product Picture
Figure 2. Global Biomaterials for Musculoskeletal Sales Market Share by Type in 2020 & 2026
Figure 3. Metallic Biomaterials Product Picture
Figure 4. Polymeric Biomaterials Product Picture
Figure 5. Inorganic Non-Metallic Biomaterials Product Picture
Figure 6. Global Biomaterials for Musculoskeletal Sales Market Share by Application in 2020 & 2026
Figure 7. Osteopathic Treatment
Figure 8. Research
Figure 9. Biomaterials for Musculoskeletal Report Years Considered
Figure 10. Global Biomaterials for Musculoskeletal Market Size 2015-2026 (US$ Million)
Figure 11. Global Biomaterials for Musculoskeletal Sales 2015-2026 (K MT)
Figure 12. Global Biomaterials for Musculoskeletal Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Biomaterials for Musculoskeletal Sales Market Share by Region (2015-2020)
Figure 14. Global Biomaterials for Musculoskeletal Sales Market Share by Region in 2019
Figure 15. Global Biomaterials for Musculoskeletal Revenue Market Share by Region (2015-2020)
Figure 16. Global Biomaterials for Musculoskeletal Revenue Market Share by Region in 2019
Figure 17. Global Biomaterials for Musculoskeletal Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Biomaterials for Musculoskeletal Revenue in 2019
Figure 19. Biomaterials for Musculoskeletal Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Biomaterials for Musculoskeletal Sales Market Share by Type (2015-2020)
Figure 21. Global Biomaterials for Musculoskeletal Sales Market Share by Type in 2019
Figure 22. Global Biomaterials for Musculoskeletal Revenue Market Share by Type (2015-2020)
Figure 23. Global Biomaterials for Musculoskeletal Revenue Market Share by Type in 2019
Figure 24. Global Biomaterials for Musculoskeletal Market Share by Price Range (2015-2020)
Figure 25. Global Biomaterials for Musculoskeletal Sales Market Share by Application (2015-2020)
Figure 26. Global Biomaterials for Musculoskeletal Sales Market Share by Application in 2019
Figure 27. Global Biomaterials for Musculoskeletal Revenue Market Share by Application (2015-2020)
Figure 28. Global Biomaterials for Musculoskeletal Revenue Market Share by Application in 2019
Figure 29. North America Biomaterials for Musculoskeletal Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Biomaterials for Musculoskeletal Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Biomaterials for Musculoskeletal Sales Market Share by Country in 2019
Figure 32. North America Biomaterials for Musculoskeletal Revenue Market Share by Country in 2019
Figure 33. U.S. Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Biomaterials for Musculoskeletal Market Share by Type in 2019
Figure 38. North America Biomaterials for Musculoskeletal Market Share by Application in 2019
Figure 39. Europe Biomaterials for Musculoskeletal Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Biomaterials for Musculoskeletal Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Biomaterials for Musculoskeletal Sales Market Share by Country in 2019
Figure 42. Europe Biomaterials for Musculoskeletal Revenue Market Share by Country in 2019
Figure 43. Germany Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Biomaterials for Musculoskeletal Market Share by Type in 2019
Figure 54. Europe Biomaterials for Musculoskeletal Market Share by Application in 2019
Figure 55. Asia Pacific Biomaterials for Musculoskeletal Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Biomaterials for Musculoskeletal Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Biomaterials for Musculoskeletal Sales Market Share by Region in 2019
Figure 58. Asia Pacific Biomaterials for Musculoskeletal Revenue Market Share by Region in 2019
Figure 59. China Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Biomaterials for Musculoskeletal Market Share by Type in 2019
Figure 82. Asia Pacific Biomaterials for Musculoskeletal Market Share by Application in 2019
Figure 83. Latin America Biomaterials for Musculoskeletal Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Biomaterials for Musculoskeletal Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Biomaterials for Musculoskeletal Sales Market Share by Country in 2019
Figure 86. Latin America Biomaterials for Musculoskeletal Revenue Market Share by Country in 2019
Figure 87. Mexico Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Biomaterials for Musculoskeletal Market Share by Type in 2019
Figure 94. Latin America Biomaterials for Musculoskeletal Market Share by Application in 2019
Figure 95. Middle East and Africa Biomaterials for Musculoskeletal Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Biomaterials for Musculoskeletal Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Biomaterials for Musculoskeletal Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Biomaterials for Musculoskeletal Revenue Market Share by Country in 2019
Figure 99. Turkey Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Biomaterials for Musculoskeletal Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Biomaterials for Musculoskeletal Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Biomaterials for Musculoskeletal Market Share by Type in 2019
Figure 106. Middle East and Africa Biomaterials for Musculoskeletal Market Share by Application in 2019
Figure 107. North America Biomaterials for Musculoskeletal Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Biomaterials for Musculoskeletal Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Biomaterials for Musculoskeletal Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Biomaterials for Musculoskeletal Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Biomaterials for Musculoskeletal Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Biomaterials for Musculoskeletal Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Biomaterials for Musculoskeletal Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Biomaterials for Musculoskeletal Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Biomaterials for Musculoskeletal Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Biomaterials for Musculoskeletal Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed